Callan Capital’s Nomura Holdings NMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$959K Buy
155,985
+18,140
+13% +$115K 0.07% 120
2024
Q4
$798K Buy
137,845
+26,100
+23% +$148K 0.06% 127
2024
Q3
$583K Buy
111,745
+4,972
+5% +$28.2K 0.04% 158
2024
Q2
$617K Buy
106,773
+13,654
+15% +$80.9K 0.05% 141
2024
Q1
$598K Buy
93,119
+58,286
+167% +$324K 0.05% 130
2023
Q4
$157K Buy
+34,833
New +$143K 0.01% 219

Other funds holding NMR

Callan Capital's NMR Position: Q1 2025 in Review

Callan Capital increased its Nomura Holdings (NMR) stake by 13% in Q1 2025, buying an estimated $115K and bringing the position to 155,985 shares worth $959K. The position accounts for 0.07% of the portfolio, ranked #120.

Callan Capital first reported a position in NMR in Q4 2023 and has held it in 6 quarters since. 204 funds tracked by Wall St. Rank hold NMR as of Q1 2025.

  • Callan Capital held 155,985 shares of Nomura Holdings worth $959K as of Q1 2025.
  • Callan Capital bought 18,140 Nomura Holdings shares in Q1 2025, an estimated $115K.
  • Nomura Holdings made up 0.07% of Callan Capital's portfolio in Q1 2025, its #120 holding.
  • Callan Capital first reported a position in Nomura Holdings in Q4 2023 and has held it in 6 quarters since.
  • 204 funds tracked by Wall St. Rank held Nomura Holdings as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.